Finance

Lists
Why is 603520 down 2,17%?
Dive Deeper
603520:SHA
Zhejiang Starry Pharmaceutical Co Ltd
CNÂ¥8,10
-2,17%
(-0,18) 1D
15 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603520...
Open
CNÂ¥8,18
High
CNÂ¥8,30
Low
CNÂ¥8,08
Mkt. cap
3,69 mjd
Avg. vol.
6,15 m
Volume
6,45 m
Dividend
3,70%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
11 Sep. 2026
P/E ratio
175,90
52-wk high
CNÂ¥14,37
52-wk low
CNÂ¥7,89
EPS
CNÂ¥0,05
Shares outstanding
120,00 m
No. of employees
2 k
Open
CNÂ¥8,18
High
CNÂ¥8,30
Low
CNÂ¥8,08
Mkt. cap
3,69 mjd
Avg. vol.
6,15 m
Volume
6,45 m
Dividend
3,70%
Quarterly dividend
CNÂ¥0,07
Ex-dividend date
11 Sep. 2026
P/E ratio
175,90
52-wk high
CNÂ¥14,37
52-wk low
CNÂ¥7,89
EPS
CNÂ¥0,05
Shares outstanding
120,00 m
No. of employees
2 k
News stories
From web sources and news partners
About Zhejiang Starry Pharmaceutical Co Ltd
CEO-
Employees1,9 k
Founded15 Sep. 1997
Headquarters-
SectorPharmaceutical industry
Websitestarrypharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
447,26 m
600,76 m
711,27 m
703,00 m
Cost of goods sold
315,76 m
530,64 m
552,98 m
594,09 m
Cost of revenue
315,76 m
530,64 m
552,98 m
594,09 m
Research and development expenses
28,97 m
37,20 m
28,28 m
30,92 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
68,25 m
55,26 m
65,75 m
65,82 m
Operating expense
85,31 m
100,75 m
96,26 m
94,33 m
Total operating expenses
401,07 m
631,39 m
649,25 m
688,43 m
Operating income
46,19 m
-30,63 m
62,02 m
14,57 m
Other non operating income
9,79 m
-17,11 m
-10,36 m
5,04 m
EBT including unusual items
-1,25 m
-30,84 m
27,63 m
26,02 m
EBT excluding unusual items
22,63 m
-46,43 m
33,32 m
14,08 m
Income tax expense
-944,92 k
-11,95 m
6,82 m
6,91 m
Effective tax rate
75,71%
38,76%
24,67%
26,56%
Other operating expenses
-8,07 m
8,64 m
-3,30 m
1,55 m
Net income
-310,63 k
-18,60 m
20,95 m
18,98 m
Net profit margin
-0,07%
-3,10%
2,95%
2,70%
Earnings per share
-
-
-
-
Interest and investment income
374,11 k
360,05 k
373,10 k
23,18 m
Interest expense
-17,36 m
-19,19 m
-18,71 m
-19,11 m
Net interest expenses
-16,99 m
-18,83 m
-18,34 m
4,06 m
Depreciation and amortization charges
-
-
-
-
EBITDA
100,91 m
28,95 m
121,60 m
74,50 m
Gain or loss from assets sale
262,77 k
-447,30 k
-
29,94 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme